Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Shares Repurchased (2024 - 2026)

Healthequity has reported Shares Repurchased over the past 3 years, most recently at $81.0 million for Q1 2026.

  • Quarterly results put Shares Repurchased at $81.0 million for Q1 2026, up 28.64% from a year ago — trailing twelve months through Jan 2026 was $299.3 million (up 146.31% YoY), and the annual figure for FY2026 was $299.3 million, up 146.31%.
  • Shares Repurchased for Q1 2026 was $81.0 million at Healthequity, down from $92.4 million in the prior quarter.
  • Over the last five years, Shares Repurchased for HQY hit a ceiling of $92.4 million in Q4 2025 and a floor of $58.5 million in Q4 2024.
  • Median Shares Repurchased over the past 3 years was $64.9 million (2025), compared with a mean of $70.1 million.
  • Biggest five-year swings in Shares Repurchased: soared 57.95% in 2025 and later increased 28.64% in 2026.
  • Healthequity's Shares Repurchased stood at $58.5 million in 2024, then soared by 57.95% to $92.4 million in 2025, then decreased by 12.34% to $81.0 million in 2026.
  • The last three reported values for Shares Repurchased were $81.0 million (Q1 2026), $92.4 million (Q4 2025), and $66.7 million (Q3 2025) per Business Quant data.